ELMD vs. BBNX, AXGN, SIBN, BVS, AVNS, KIDS, ZIMV, TMCI, SMLR, and CBLL
Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include Beta Bionics (BBNX), AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), AVANOS MEDICAL (AVNS), OrthoPediatrics (KIDS), ZimVie (ZIMV), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), and CeriBell (CBLL). These companies are all part of the "medical equipment" industry.
Electromed vs. Its Competitors
Beta Bionics (NASDAQ:BBNX) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.
In the previous week, Beta Bionics had 10 more articles in the media than Electromed. MarketBeat recorded 16 mentions for Beta Bionics and 6 mentions for Electromed. Electromed's average media sentiment score of 0.88 beat Beta Bionics' score of 0.79 indicating that Electromed is being referred to more favorably in the news media.
Beta Bionics presently has a consensus target price of $22.56, suggesting a potential downside of 14.59%. Electromed has a consensus target price of $36.25, suggesting a potential upside of 51.80%. Given Electromed's stronger consensus rating and higher possible upside, analysts clearly believe Electromed is more favorable than Beta Bionics.
Electromed has lower revenue, but higher earnings than Beta Bionics.
40.8% of Electromed shares are held by institutional investors. 14.0% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Electromed has a net margin of 11.34% compared to Beta Bionics' net margin of 0.00%. Electromed's return on equity of 15.71% beat Beta Bionics' return on equity.
Summary
Electromed beats Beta Bionics on 9 of the 13 factors compared between the two stocks.
Get Electromed News Delivered to You Automatically
Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Electromed Competitors List
Related Companies and Tools
This page (NYSE:ELMD) was last updated on 9/13/2025 by MarketBeat.com Staff